Jelvoxa Dmso Cream
NDC Package 88041-002-01

11-digit billing NDC: 88041000201
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Jelvoxa Dmso (menthol camphor capsaicin) cream is a human otc drug administered via transdermal route. This formulation utilizes a cream delivery system. Marketed by Vange Life Technology Co., Limited, this product is identified by NDC 88041-002 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
88041-002-01
Package Description
120 g in 1 BOTTLE
Product Code
88041-002
11-Digit Billing Format
88041000201

Clinical Specifications

Proprietary Name
Jelvoxa Dmso
Non-Proprietary Name
Menthol Camphor Capsaicin
Substance Name
Camphor (synthetic); Menthol; Capsaicin
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Vange Life Technology Co., Limited
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-08-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 88041-002-01 identifies a specific commercial package of 120 g in 1 bottle of Jelvoxa Dmso, a human over the counter drug labeled by Vange Life Technology Co., Limited. This cream is formulated for transdermal use and contains camphor (synthetic); menthol; capsaicin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vange Life Technology Co., Limited on October 08, 2026. The current certification is valid through December 31, 2027.

How is this Vange Life Technology Co., Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 88041000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
88041-002-01
11-Digit CMS (5-4-2)
88041-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.